Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: Two clinical trials in healthy volunteers and patients with hereditary angioedema
- 31 December 2008
- journal article
- research article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 30 (12), 2314-2323
- https://doi.org/10.1016/j.clinthera.2008.12.021
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- High-Density Lipoprotein Attenuates Inflammation and Coagulation Response on Endotoxin Challenge in HumansArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- High-Density Lipoprotein and the Risk of Recurrent Venous ThromboembolismCirculation, 2007
- Increased Plasma C-Reactive Protein in Familial HypoalphalipoproteinemiaCirculation, 2002
- Danazol and plasma lipoprotein metabolismInternational Journal of Gynecology & Obstetrics, 1995
- Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acidJournal of Allergy and Clinical Immunology, 1994
- A Comparative Treatment Trial of Endometriosis Using the Gonadotrophin‐releasing Hormone Agonist, Nafarelin, and the Synthetic Steroid, DanazolAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1991
- Zoladex versus Danazol in the Treatment of Pelvic Endometriosis: Effects on Plasma Lipid Risk FactorsHormone Research, 1989
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbitNature, 1985
- Changes of Plasma Lipids and Lipoprotein Levels during Danazol Treatment for EndometriosisHormone and Metabolic Research, 1984